from Stocks-Markets-Economic Times https://ift.tt/3qnTZ4a
Home »
Stocks-Markets-Economic Times
» AstraZeneca Pharma India Q2 results: Net profit declines 55% to Rs 12 cr
AstraZeneca Pharma India Q2 results: Net profit declines 55% to Rs 12 cr
from Stocks-Markets-Economic Times https://ift.tt/3qnTZ4a
Related Posts:
SBI’s flagship Yono App faces outageSBI which has a customer base of 490 million, processes at least 4 lakh transactions on its digital offerings on a daily basis. About 55% of the bank’s transactions are currently being conducted through the digital channel an… Read More
ETMarkets Morning Podcast: Investors rush into midcaps from Stocks-Markets-Economic Times https://ift.tt/36xHnwK … Read More
Sambandh Fin diverted Rs 100 cr to cos linked to its promotersThe company diverted funds to entities such as Diya Dairy & Agroprocessors Pvt Ltd, Kshama Foundation, Regional Rural Development Centre (RRDC), DK Enterprises, Utkal Dairy. Funds were also diverted to individuals, people… Read More
SGX Nifty up 10 points; here's what changed for market while you were sleepingNifty50 tested the 13,000 level on Wednesday, before rebounding and closing in the black. The index formed a Dragonfly Doji pattern on the daily chart, suggesting a balance of power between the bulls and the bears. from Stoc… Read More
UltraTech to invest in Rs 5,477-cr expansion planGiven its pan-India presence which will be further strengthened by the capacity expansion, UltraTech will be well-positioned to support the rising demand for cement in the country, Birla added. from Stocks-Markets-Economic T… Read More
0 Comments:
Post a Comment